VCYT

NASDAQ · Biotechnology

Veracyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$47.22

+1.07 (+2.32%)

As of Aug 8, 1:31 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 83%

Hold 2 11%

Sell 1 6%

Price Target

Analyst Price Target -0.8% upside

Low Target $30.44

Average Target $46.85

High Target $57.64

Current Price $47.22

Current
$47.22

Target
$46.85

$30.44 $46.85 avg $57.64

Scenario Analysis

Bear Case

$30.44

-35.5%

Low target

Base Case

$46.85

-0.8%

Avg target

Bull Case

$57.64

+22.1%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$60.91

-22.5% from high

52-Week Low

$23.79

+98.5% from low

50-Day SMA

$40.85

+15.6% vs SMA

200-Day SMA

$34.09

+38.5% vs SMA

RSI (14)

37.6

Neutral

Target vs 52W High

$46.85

-23.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%